top of page
  • LinkedIn

Rob Dickey, IV 

Focus: Finance

C-Suite Executive in the Life Sciences

Career Highlights

  • Managing Director, Mid Atlantic Region, Danforth Advisors

  • Danforth’s services range from day-to-day finance and accounting functions to strategic CFO advisory, financial planning and analysis, and transactional support/execution for public offerings and M&A, solely for life science companies 

  • Board of Directors and Audit Committee Chairman of Emmaus Life Sciences

  • Rob is experienced in all stages of the corporate lifecycle, including start-up operations, high growth, turnarounds and exit strategies

  • Expertise includes public and private financings, M&A, partnering/licensing transactions, project management and Chapter 11 reorganizations, as well as interactions with boards, venture capitalists, shareholders and Wall Street

  • Prior to joining Danforth, Rob served as CFO to multiple companies, including Motif Bio (NASDAQ/AIM: MTFB), Tyme Technologies, Inc. (NASDAQ: TYME), BeyondSpring Pharmaceuticals, Inc., and NeoStem, Inc. – now Caladrius Biosciences, Inc. (NASDAQ: CLBS)

  • He previously spent nearly 20 years in investment banking at Lehman Brothers and Legg Mason


  • AB: Princeton University

  • MBA: The Wharton School, University of Pennsylvania

bottom of page